102 related articles for article (PubMed ID: 27318264)
1. Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort.
Wang EH; Yu JB; Abouassally R; Meropol NJ; Cooper G; Shah ND; Williams SB; Gonzalez C; Smaldone MC; Kutikov A; Zhu H; Kim SP
Urology; 2016 Sep; 95():88-94. PubMed ID: 27318264
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
Eur Urol; 2017 Oct; 72(4):534-541. PubMed ID: 27816297
[TBL] [Abstract][Full Text] [Related]
3. Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals.
Krimphove MJ; Fletcher SA; Cole AP; Berg S; Sun M; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Kluth LA; Weissman JS; Trinh QD
J Urol; 2019 Apr; 201(4):735-741. PubMed ID: 30414956
[TBL] [Abstract][Full Text] [Related]
4. Association of race with receipt of definitive therapy for high risk prostate cancer in older men.
Patel SA; Liu Y; Mahal BA; Jani AB; Sanda MG; Royce TJ; Fischer-Valuck BW
J Geriatr Oncol; 2022 Mar; 13(2):200-206. PubMed ID: 34563484
[TBL] [Abstract][Full Text] [Related]
5. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups.
Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
Urology; 2014 Aug; 84(2):386-92. PubMed ID: 24975710
[TBL] [Abstract][Full Text] [Related]
6. Variations in quality of care for men with early-stage prostate cancer.
Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
[TBL] [Abstract][Full Text] [Related]
7. Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort.
Kiechle JE; Abouassaly R; Gross CP; Dong S; Cherullo EE; Zhu H; Trinh QD; Sun M; Meropol NJ; Hoimes CJ; Ialacci S; Kim SP
Urology; 2016 Apr; 90():69-74. PubMed ID: 26724412
[TBL] [Abstract][Full Text] [Related]
8. Sociodemographic Disparities in Cure-Intended Treatment in Localized Prostate Cancer.
des Bordes JKA; Lopez DS; Swartz MD; Volk RJ
J Racial Ethn Health Disparities; 2018 Feb; 5(1):104-110. PubMed ID: 28205153
[TBL] [Abstract][Full Text] [Related]
9. Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?
Moses KA; Orom H; Brasel A; Gaddy J; Underwood W
Urology; 2017 Jan; 99():76-83. PubMed ID: 27667157
[TBL] [Abstract][Full Text] [Related]
10. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.
Jeong CW; Washington SL; Herlemann A; Gomez SL; Carroll PR; Cooperberg MR
Eur Urol; 2020 Sep; 78(3):335-344. PubMed ID: 31980309
[TBL] [Abstract][Full Text] [Related]
11. Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer.
Moses KA; Orom H; Brasel A; Gaddy J; Underwood W
Urol Oncol; 2016 Sep; 34(9):415.e7-415.e12. PubMed ID: 27161898
[TBL] [Abstract][Full Text] [Related]
12. Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy.
Kim SP; Boorjian SA; Shah ND; Weight CJ; Tilburt JC; Han LC; Thompson RH; Trinh QD; Sun M; Moriarty JP; Karnes RJ
J Urol; 2013 Feb; 189(2):514-20. PubMed ID: 23253307
[TBL] [Abstract][Full Text] [Related]
13. Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database.
Wang EH; Yu JB; Gross CP; Smaldone MC; Shah ND; Trinh QD; Nguyen PL; Sun M; Han LC; Kim SP
J Urol; 2015 Mar; 193(3):820-5. PubMed ID: 25242393
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center.
Thomsen FB; Mikkelsen MK; Hansen RB; Krug AH; Glenthøj A; Stattin P; Brasso K
Acta Oncol; 2016 Dec; 55(12):1456-1460. PubMed ID: 27333339
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.
Huang D; Ruan X; Huang J; Zhang N; Jiang G; Gao Y; Xu D; Na R
Cancer Med; 2023 Apr; 12(8):9868-9878. PubMed ID: 36727535
[TBL] [Abstract][Full Text] [Related]
16. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.
Berglund A; Garmo H; Robinson D; Tishelman C; Holmberg L; Bratt O; Adolfsson J; Stattin P; Lambe M
Eur J Cancer; 2012 Jan; 48(1):75-84. PubMed ID: 21852113
[TBL] [Abstract][Full Text] [Related]
17. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
[TBL] [Abstract][Full Text] [Related]
18. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.
Carter CA; Donahue T; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Jackmaan S; Moul JW
J Clin Oncol; 2003 Nov; 21(21):4001-8. PubMed ID: 14581423
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer.
Hou WH; Daly ME; Lee NY; Farwell DG; Luu Q; Chen AM
Arch Otolaryngol Head Neck Surg; 2012 Jul; 138(7):644-9. PubMed ID: 22801888
[TBL] [Abstract][Full Text] [Related]
20. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
